Literature DB >> 17868360

Specific mutations in the Mycobacterium tuberculosis rpoB gene are associated with increased dnaE2 expression.

Indra L Bergval1, Paul R Klatser, Anja R J Schuitema, Linda Oskam, Richard M Anthony.   

Abstract

In Mycobacterium tuberculosis (MTB), rifampicin resistance is almost invariably due to mutations in the rpoB gene, whose function is critical for cell viability. Most of these mutations, at least initially, impair the fitness of the bacteria but confer a selective advantage when antibiotic pressure is exerted. Subsequent adaptation may be critical to restore fitness. The possibility was considered that MTB with mutations in the rpoB gene elicits a constitutive stress response, increasing the probability of subsequent adaptation. In order to test this hypothesis, the expression of recA and dnaE2, an inducible putative error-prone DNA polymerase, was determined in six different isogenic laboratory-generated rpoB-mutants of MTB. Expression levels were determined with real-time PCR and the data obtained were compared with those of the wild-type parent. In four of the six rpoB mutants, a two- to fivefold induction of dnaE2 was detected (P<0.05). Thus, the presence of specific mutations in rpoB is not only associated with impaired fitness but also results in a detectable, moderate yet persistent increase in the expression of dnaE2 but not recA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868360     DOI: 10.1111/j.1574-6968.2007.00905.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model.

Authors:  Shashwat Deepali Nagar; Bhavye Aggarwal; Shikha Joon; Rakesh Bhatnagar; Sonika Bhatnagar
Journal:  OMICS       Date:  2016-05

2.  Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.

Authors:  Muhamed-Kheir Taha; Sara Thulin Hedberg; Marek Szatanik; Eva Hong; Corinne Ruckly; Raquel Abad; Sophie Bertrand; Francoise Carion; Heike Claus; Alejandra Corso; Rocío Enríquez; Sigrid Heuberger; Waleria Hryniewicz; Keith A Jolley; Paula Kriz; Marta Mollerach; Martin Musilek; Arianna Neri; Per Olcén; Marina Pana; Anna Skoczynska; Cecilia Sorhouet Pereira; Paola Stefanelli; Georgina Tzanakaki; Magnus Unemo; Julio A Vázquez; Ulrich Vogel; Izabela Wasko
Journal:  Antimicrob Agents Chemother       Date:  2010-07-06       Impact factor: 5.191

3.  Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis.

Authors:  Gregory P Bisson; Carolina Mehaffy; Corey Broeckling; Jessica Prenni; Dalin Rifat; Desmond S Lun; Marcos Burgos; Drew Weissman; Petros C Karakousis; Karen Dobos
Journal:  J Bacteriol       Date:  2012-09-21       Impact factor: 3.490

4.  Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro.

Authors:  Indra Bergval; Brian Kwok; Anja Schuitema; Kristin Kremer; Dick van Soolingen; Paul Klatser; Richard Anthony
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

5.  Multiple strategies for translesion synthesis in bacteria.

Authors:  Paul J Ippoliti; Nicholas A Delateur; Kathryn M Jones; Penny J Beuning
Journal:  Cells       Date:  2012-10-15       Impact factor: 6.600

Review 6.  The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?

Authors:  Anastasia Koch; Valerie Mizrahi; Digby F Warner
Journal:  Emerg Microbes Infect       Date:  2014-03-12       Impact factor: 7.163

7.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790

8.  Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Alice L den Hertog; Sandra Menting; Ernst T Smienk; Jim Werngren; Sven Hoffner; Richard M Anthony
Journal:  BMC Infect Dis       Date:  2014-07-10       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.